Celltrion Pharm, Inc.

A068760

KR7068760008

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 03:30:00 24/05/2024 am IST			5-day change	1st Jan Change
91,600 ^KRW	-1.29%		-4.38%	-0.65%

16/01	Celltrion Holdings Actively Pursuing Nasdaq Listing	MT
02/01	Celltrion's Shares Climb After Merger With Affiliate	DJ

Celltrion Pharm Inc. Reports Earnings Results for the Year Ended December 31, 2015

March 31, 2016

Celltrion Pharm Inc. reported earnings results for the year ended December 31, 2015. For the period, the company reported revenue of KRW 72,578,429,000 and profit for the year of KRW 7,386,732,000.

Latest news about Celltrion Pharm, Inc.

Celltrion Holdings Actively Pursuing Nasdaq Listing	16/01	MT
Celltrion's Shares Climb After Merger With Affiliate	02/01	DJ
S.Korean shares end slightly higher as chipmakers advance; US CPI in focus	11/12	RE
South Korean Shares Decline on Concerns over US Fed Rate Hike, China Economic Turmoil	18/23/18	MT
Celltrion Discloses Merger Plans with Celltrion HealthCare; Celltrion Shares Jump 5%	18/23/18	MT
Exclusive-Thermo Fisher, Celltrion vie for Baxter's biopharma unit -sources	21/23/21	RE
South Korean Stocks Rise on Gains by Batterymakers; Samsung SDI Stock Rises 2%	07/23/07	MT
Celltrion Group Creator Expected to Resume Leadership Role	07/23/07	MT
Fosun Pharma, Other Chinese Drugmakers Rise After Deal to Make Merck's Covid-19 Pill	21/22/21	DJ
Celltrion : South Korea approves Celltrion's COVID-19 treatment for use	17/21/17	RE
Samsung Electronics : S.Korea shares dip as surging global coronavirus cases dent sentiment	26/20/26	RE
Celltrion : South Korea pharma Celltrion's COVID test gets U.S. emergency use authorisation	26/20/26	RE
Celltrion Pharm : S.Korea pharma Celltrion's COVID test gets U.S. emergency use authorisation	26/20/26	RE
Samsung Electronics : S.Korea shares jump most in two weeks on falling virus cases, upbeat China data	28/20/28	RE
Celltrion : South Korea's Celltrion to merge with affiliates to set up holding company structure	25/20/25	RE
Celltrion Pharm, Inc.(KOSDAQ:A068760) added to FTSE All-World Index	21/20/21	CI
Celltrion Pharm Inc. Reports Earnings Results for the Year Ended December 31, 2017	02/18/02	CI
Celltrion Pharm Inc. Reports Earnings Results for the Year Ended December 31, 2016	11/17/11	CI
Teva Pharmaceutical May Buy Celltrion	17/16/17	CI
Celltrion Pharm Inc. Reports Earnings Results for the Quarter and Period Ended June 30, 2016	12/16/12	CI
Celltrion Pharm Inc. Reports Earnings Results for the Year Ended December 31, 2015	31/16/31	CI
Celltrion Pharm Inc. Reports Earnings Results for the Quarter and Period Ended September 30, 2015	12/15/12	CI
Celltrion Pharm Inc. Reports Earnings Results for the Quarter and Six Months Ended June 30, 2015	13/15/13	CI
Celltrion Pharm Inc.(KOSDAQ:A068760) added to Russell Global Index	29/15/29	CI
Celltrion Pharm Inc.(KOSDAQ:A068760) added to MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index	01/15/01	CI

Celltrion Pharm Inc is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The Companyâs products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. It also provides ethical drugs and over-the-counter (OTC) drugs. The Company distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.

Sector

Pharmaceuticals

Calendar

13/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
CELLTRION PHARM, INC.	-0.65%	2.78B
SUN PHARMACEUTICAL INDUSTRIES LTD.	+18.04%	42.95B
OTSUKA HOLDINGS CO., LTD.	+16.92%	21.38B
SANDOZ GROUP AG	+18.33%	15.05B
CIPLA LIMITED	+19.27%	14.45B
ZYDUS LIFESCIENCES LIMITED	+56.12%	13.04B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-10.73%	6.72B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+11.21%	5.47B

Generic Pharmaceuticals